Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FMEH8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,925
Award facts
- Contract value 100% obligated
- $29,925.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,925 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA PEN 30 MG/ML. The delivery order, issued on January 30, 2026, with an ultimate completion date of February 2, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal military pharmaceutical supply chain through consistent performance on numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division. The company's established prime vendor contract, designated SPE2DR and valued at $499,999,999, extends through December 31, 2036, with a 30-month base period and three 30-month option periods. This delivery order for FASENRA, a biologic medication, exemplifies the company's role in distributing specialized pharmaceuticals, biologics, and medical consumables essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FMEH8?
SPE2DR26FMEH8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FMEH8 worth?
The government has obligated $29,925 on SPE2DR26FMEH8.
Is contract SPE2DR26FMEH8 an order under another contract?
Yes. SPE2DR26FMEH8 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEH8 competed?
The extent of competition for SPE2DR26FMEH8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award